OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of immunosenescence and inflammaging on the effects of immune checkpoint inhibitors
Chuandong Hou, Zining Wang, Xuechun Lu
Cancer Pathogenesis and Therapy (2023) Vol. 2, Iss. 1, pp. 24-30
Open Access | Times Cited: 9

Showing 9 citing articles:

Oxidative Stress and Age-Related Tumors
Emma Di Carlo, Carlo Sorrentino
Antioxidants (2024) Vol. 13, Iss. 9, pp. 1109-1109
Open Access | Times Cited: 17

Immunosenescence and Inflammaging: Mechanisms and Role in Diseases
Amir Ajoolabady, Domenico Praticò, Daolin Tang, et al.
Ageing Research Reviews (2024) Vol. 101, pp. 102540-102540
Closed Access | Times Cited: 11

Catching the STING: Unlocking Senescence and PD-L1 in PBC
Pierre‐Antoine Soret, Jérémie Gautheron
Clinics and Research in Hepatology and Gastroenterology (2025) Vol. 49, Iss. 2, pp. 102526-102526
Closed Access

Exploring the Complexity and Promise of Tumor Immunotherapy in Drug Development
Yiyuan Feng, Caiying He, Chang Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6444-6444
Open Access | Times Cited: 2

Cellular Senescence in Liver Cancer: How Dying Cells Become “Zombie” Enemies
Aurora Gazzillo, Camilla Volponi, Cristiana Soldani, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 26-26
Open Access | Times Cited: 5

Advanced molecular diagnostics: Driving precision in hematological malignancies
Yuan Chen, Xuechun Lu, Yaozhu Pan
Cancer Pathogenesis and Therapy (2024)
Open Access | Times Cited: 1

Blood based immune biomarkers associated with clinical frailty scale in older patients with melanoma receiving checkpoint inhibitor immunotherapy
Estelle Tran Van Hoi, Saskia J. Santegoets, Simon P. Mooijaart, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 1

[Current Status and Prospect of PD-1/PD-L1 Immune Checkpoint Inhibitor Therapy 
in Elderly Patients with Advanced NSCLC].
Yun-ye Mao, Shu Li Sheng, An Wang, et al.
PubMed (2024) Vol. 27, Iss. 5, pp. 367-375
Closed Access

Page 1

Scroll to top